Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Voigt, Alexandria ^a   Esfandiary, Lida ^a   Wanchoo, Arun ^a   Glenton, Patricia ^a   Donate, Amy ^a   Craft, William F ^a   Craft, Serena L M ^a   Nguyen, Cuong Q ^a,b  

^a University of Florida College of Veterinary Medicine   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

ANIMAL; B LYMPHOCYTE; DISEASE MODEL; FEMALE; GENETICS; GERMINAL CENTER; IMMUNOLOGY; MALE; MOUSE; PATHOLOGY; SALIVARY GLAND; SEXUAL CHARACTERISTICS; SJOEGREN SYNDROME; TH2 CELL;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; GERMINAL CENTER; INTERLEUKIN-17; MALE; MICE; SALIVARY GLANDS; SEX CHARACTERISTICS; SJOGREN'S SYNDROME; TH2 CELLS;

EID: 85006074130     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38717     Document Type: Article

References (61)

1. Fox, R. I. Sjogren's syndrome. Lancet 366, 321-331 (2005).
2. Nguyen, C. Q. & Peck, A. B. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf 7, 11-27 (2009).
3. Weng, M. Y., Huang, Y. T., Liu, M. F. & Lu, T. H. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan. Annals of the rheumatic diseases 71, 524-527, doi: 10.1136/annrheumdis-2011-200402 (2012).
4. Solans-Laque, R. et al. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjogren's syndrome. Semin Arthritis Rheum 41, 415-423, doi: 10.1016/j.semarthrit.2011.04.006 (2011).
5. Vitali, C. et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554-558 (2002).
6. Jonsson, M. V., Skarstein, K., Jonsson, R. & Brun, J. G. Serological implications of germinal center-like structures in primary Sjogren's syndrome. J Rheumatol 34, 2044-2049, doi: 07/13/096 (2007).
7. Reksten, T. R. et al. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Sunnyvale) 48, 1102-1106, doi: 10.1093/rheumatology/kep149 (2009).
8. Nguyen, C. Q., Hu, M. H., Li, Y., Stewart, C. & Peck, A. B. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: Findings in humans and mice. Arthritis Rheum 58, 734-743, doi: 10.1002/art.23214 (2008).
9. Alunno, A. et al. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjogren's syndrome. Reumatismo 65, 192-198, doi: 10.4081/reumatismo.2013.192 (2013).
10. Sakai, A., Sugawara, Y., Kuroishi, T., Sasano, T. & Sugawara, S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181, 2898-2906, doi: 181/4/2898 (2008).
11. Alunno, A. et al. IL-17-producing CD4-CD8-T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. Annals of the rheumatic diseases 72, 286-292, doi: 10.1136/annrheumdis-2012-201511 (2013).
12. Nguyen, C. Q. et al. Pathogenic effect of interleukin-17A in induction of Sjogren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis research & therapy 12, R220, doi: 10.1186/ar3207 (2010).
13. Nguyen, C. Q., Yin, H., Lee, B. H., Chiorini, J. A. & Peck, A. B. IL17: potential therapeutic target in Sjogren's syndrome using adenovirus-mediated gene transfer. Laboratory investigation; a journal of technical methods and pathology 91, 54-62, doi: 10.1038/labinvest.2010.164 (2011).
14. Lin, X. et al. Th17 cells play a critical role in the development of experimental Sjogren's syndrome. Annals of the rheumatic diseases, doi: 10.1136/annrheumdis-2013-204584 (2014).
15. Katsifis, G. E., Rekka, S., Moutsopoulos, N. M., Pillemer, S. & Wahl, S. M. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 175, 1167-1177, doi: 10.2353/ajpath.2009.090319 (2009).
16. Sullivan, D. A. Sex hormones and Sjogren's syndrome. J. Rheumatol. Suppl. 50, 17-32 (1997).
17. Whitacre, C. C. Sex differences in autoimmune disease. Nature immunology 2, 777-780, doi: 10.1038/ni0901-777 (2001).
18. Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194, 519-527 (2001).
19. Roussel, L. et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. Journal of immunology 184, 4531-4537, doi: 10.4049/jimmunol.0903162 (2010).
20. Disteldorf, E. M. et al. CXCL5 drives neutrophil recruitment in TH17-mediated GN. J Am Soc Nephrol 26, 55-66, doi: 10.1681/ASN.2013101061 (2015).
21. Lee, B. H., Tudares, M. A. & Nguyen, C. Q. Sjogren's syndrome: an old tale with a new twist. Arch Immunol Ther Exp (Warsz) 57, 57-66, doi: 10.1007/s00005-009-0002-4 (2009).
22. Voigt, A., Esfandiary, L. & Nguyen, C. Q. Sexual dimorphism in an animal model of Sjogren's syndrome: a potential role for Th17 cells. Biology Open, doi: 10.1242/bio.013771 (2015).
23. Iizuka, M. et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis. Journal of autoimmunity 35, 383-389, doi: 10.1016/j.jaut.2010.08.004 (2010).
24. Khan, D., Dai, R., Karpuzoglu, E. & Ahmed, S. A. Estrogen increases, whereas IL-27 and IFN-gamma decrease, splenocyte IL-17 production in WT mice. Eur J Immunol 40, 2549-2556, doi: 10.1002/eji.201040303 (2010).
25. Oertelt-Prigione, S. The influence of sex and gender on the immune response. Autoimmun Rev 11, A479-485, doi: 10.1016/j. autrev.2011.11.022 (2012).
26. Fijak, M. et al. Testosterone replacement effectively inhibits the development of experimental autoimmune orchitis in rats: evidence for a direct role of testosterone on regulatory T cell expansion. Journal of immunology 186, 5162-5172, doi: 10.4049/jimmunol.1001958 (2011).
27. Cutolo, M. et al. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Annals of the New York Academy of Sciences 966, 131-142 (2002).
28. Konttinen, Y. T. et al. Sex steroids in Sjogren's syndrome. Journal of autoimmunity 39, 49-56, doi: 10.1016/j.jaut.2012.01.004 (2012).
29. Spaan, M. et al. Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjogren's syndrome. J Cell Mol Med 13, 1261-1270, doi: 10.1111/j.1582-4934.2009.00727.x (2009).
30. Porola, P. et al. Androgens and integrins in salivary glands in Sjogren's syndrome. The Journal of rheumatology 37, 1181-1187, doi: 10.3899/jrheum.091354 (2010).
31. Brayer, J. et al. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy. J Rheumatol 27, 1896-1904 (2000).
32. Cha, S., Nagashima, H., Brown, V. B., Peck, A. B. & Humphreys-Beher, M. G. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background. Arthritis. Rheum. 46, 1390-1398 (2002).
33. Cuello, C. et al. Chemokine expression and leucocyte infiltration in Sjogren's syndrome. Br J Rheumatol 37, 779-783 (1998).
34. Kapsogeorgou, E. K., Dimitriou, I. D., Abu-Helu, R. F., Moutsopoulos, H. M. & Manoussakis, M. N. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjogren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 124, 126-133 (2001).
35. Kong, L. et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 40, 87-97 (1997).
36. Kong, L. et al. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 16, 675-681 (1998).
37. Cha, S. et al. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60, 552-565 (2004).
38. Willeke, P. et al. Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjogren's syndrome. Annals of the rheumatic diseases 62, 359-362 (2003).
39. Shinbori, T., Walczak, H. & Krammer, P. H. Activated T killer cells induce apoptosis in lung epithelial cells and the release of proinflammatory cytokine TNF-alpha. Eur J Immunol 34, 1762-1770, doi: 10.1002/eji.200425097 (2004).
40. Nguyen, C. et al. Role of complement and B lymphocytes in Sjogren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice. Mol. Immunol. 43, 1332-1339 (2006).
41. Manoussakis, M. N. & Kapsogeorgou, E. K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. Journal of autoimmunity 35, 219-224, doi: 10.1016/j.jaut.2010.06.011 (2010).
42. Tsunawaki, S. et al. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjogren's syndrome. The Journal of rheumatology 29, 1884-1896 (2002).
43. You, I. C., Bian, F., Volpe, E. A., de Paiva, C. S. & Pflugfelder, S. C. Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjogren Syndrome Develops Independent of Lacrimal Dysfunction. Investigative ophthalmology & visual science 56, 2224-2233, doi: 10.1167/iovs.14-15668 (2015).
44. Ota, M. et al. A significant induction of neutrophilic chemoattractants but not RANKL in synoviocytes stimulated with interleukin 17. J Bone Miner Metab 33, 40-47, doi: 10.1007/s00774-014-0565-y (2015).
45. Barin, J. G. et al. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol 42, 726-736, doi: 10.1002/eji.201141737 (2012).
46. Fei, M. et al. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proceedings of the National Academy of Sciences of the United States of America 108, 5360-5365, doi: 10.1073/pnas.1015476108 (2011).
47. Mitsdoerffer, M. et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA 107, 14292-14297, doi: 10.1073/pnas.1009234107 (2010).
48. Pisitkun, P. et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37, 1104-1115, doi: 10.1016/j.immuni.2012.08.014 (2012).
49. Nguyen, C. Q., Cha, S. R. & Peck, A. B. Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Frontiers in Bioscience 12, 1767-1789 (2007).
50. Bermejo, D. A. et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nature immunology 14, 514-522, doi: 10.1038/ni.2569 (2013).
51. Hsu, H. C. et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9, 166-175, doi: 10.1038/ni1552 (2008).
52. Venkatesh, J., Peeva, E., Xu, X. & Diamond, B. Cutting Edge: Hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J Immunol 176, 3311-3314 (2006).
53. Ansar Ahmed, S., Dauphinee, M. J., Montoya, A. I. & Talal, N. Estrogen induces normal murine CD5+ B cells to produce autoantibodies. Journal of immunology 142, 2647-2653 (1989).
54. Wilhelmson, A. S. et al. Androgens regulate bone marrow B lymphopoiesis in male mice by targeting osteoblast-lineage cells. Endocrinology 156, 1228-1236, doi: 10.1210/en.2014-1822 (2015).
55. Sato, E. H., Ariga, H. & Sullivan, D. A. Impact of androgen therapy in Sjogren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Investigative ophthalmology & visual science 33, 2537-2545 (1992).
56. Nguyen, C. Q. et al. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjogren's syndrome-like disease of the nonobese diabetic mouse. J Immunol 179, 382-390, doi: 179/1/382 (2007).
57. Ishimaru, N. et al. Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. The Journal of experimental medicine 205, 2915-2927, doi: 10.1084/jem.20080174 (2008).
58. Ishimaru, N. et al. Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands. Mol Cell Biol 26, 2924-2935, doi: 10.1128/MCB.26.8.2924-2935.2006 (2006).
59. Bian, F. et al. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjogren's syndrome. Arthritis research & therapy 17, 53, doi: 10.1186/s13075-015-0582-9 (2015).
60. Nguyen, C. Q. et al. Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Arthritis Res Ther 11, R56, doi: 10.1186/ar2676 (2009).
61. Cha, S., Nagashima, H., Peck, A. B. & Humphreys-Beher, M. G. IDD3 and IDD5 alleles from nod mice mediate Sjogren's syndromelike autoimmunity. Advances in experimental medicine and biology 506, 1035-1039 (2002).